indoleacetic acid and Cardiovascular Diseases

indoleacetic acid has been researched along with Cardiovascular Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Benvenga, S; Buemi, M; Calabrese, V; Cernaro, V; Cigala, RM; Corsaro, R; Crea, F; De Stefano, C; Ferlazzo, VT; Gembillo, G; Loddo, S; Longhitano, E; Macaione, V; Romeo, A; Santoro, D1
Borges, NA; Brito, JS; Esgalhado, M; Mafra, D; Magliano, DC; Soulage, CO1
Brunet, P; Burtey, S; Calaf, R; Cerini, C; Dignat-George, F; Dou, L; Dussol, B; Fallague, K; Gondouin, B; Jourde-Chiche, N; Mallet, B; Poitevin, S; Sallée, M1
Liabeuf, S; Massy, ZA; Villain, C1
Boelaert, J; Eloot, S; Glorieux, G; Lynen, F; Sandra, P; Van Landschoot, M; Vanholder, R; Waterloos, MA1
BARONI, G; CIPRIANI, D; SANTILLI, E1

Reviews

2 review(s) available for indoleacetic acid and Cardiovascular Diseases

ArticleYear
Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Nephron, 2017, Volume: 137, Issue:1

    Topics: Animals; Cardiovascular Diseases; Glucuronates; Humans; Indican; Indoleacetic Acids; Indoles; Models, Biological; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Toxins, Biological; Tryptophan; Uremia

2017
Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
    Clinical science (London, England : 1979), 2016, 12-01, Volume: 130, Issue:23

    Topics: Animals; Cardiovascular Diseases; Cresols; Humans; Indican; Indoleacetic Acids; Proteins; Renal Insufficiency, Chronic; Sulfuric Acid Esters; Uremia

2016

Other Studies

4 other study(ies) available for indoleacetic acid and Cardiovascular Diseases

ArticleYear
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients.
    International urology and nephrology, 2022, Volume: 54, Issue:9

    Topics: Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Female; Humans; Indoleacetic Acids; Lipoproteins, HDL; Male; Monocytes; Renal Insufficiency, Chronic

2022
The cardiovascular effect of the uremic solute indole-3 acetic acid.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cyclooxygenase 2; Endothelium, Vascular; Female; Human Umbilical Vein Endothelial Cells; Humans; Indoleacetic Acids; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Young Adult

2015
A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
    Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6

    Topics: Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Cresols; Female; Furans; Glucuronides; Hippurates; Humans; Indican; Indoleacetic Acids; Male; Propionates; Renal Insufficiency, Chronic; Severity of Illness Index; Sulfuric Acid Esters; Tandem Mass Spectrometry; Uremia; Uric Acid

2013
[Urinary elimination of 5-hydroxyindolacetic acid in different aspects of human pathology].
    L' Ospedale maggiore, 1962, Volume: 50

    Topics: Cardiovascular Diseases; Gastroenterology; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Kidney Diseases; Lung Abscess; Neoplasms; Serotonin

1962